CL16019, A Combination of <i>Cissus quadrangularis</i> and <i>Boswellia serrata</i> Extracts Promotes the Healing of Distal Radius Fractures: A Multicentric, Randomized, Open-Label Study

Supplementation of CL16019 along with standard therapy was found to enhance the bone fracture healing rate, possibly by accelerating the callus formation rate and enhancing cortical bridging. These findings imply that CL16019 might be a good adjunctive in addition to ST for the faster healing of DRFs. The trial was registered with the Clinical Trial Registry of India (CTRI) with the registration number CTRI/2021/12/039006, on December 29, 2021.